Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Neurology

Daily Life, Care Team, and Emergencies

At a Glance

Living with PADMAL involves coordinated neurology, genetics, and rehabilitation care, plus monitoring of eye and kidney involvement. Know your usual symptoms, keep an emergency card, and call emergency services for sudden neurologic changes such as new weakness, facial droop, or speech changes.

Managing PADMAL is a marathon, not a sprint. Because it is a progressive and rare condition, you need a specialized “village” of providers who understand how the disease works [1][2]. While much of your care will focus on monitoring and protecting your blood vessels, preparing for the future and knowing when to act are the most empowering steps you can take.

Building Your Multi-Specialty Team

A standard neurology clinic may not be enough for PADMAL. Ideally, your care should be coordinated by a multidisciplinary team that communicates with one another. If a rare-disease center is not accessible, a local neurologist can coordinate with specialists [1][2].

  • Vascular Neurologist: A stroke specialist who understands the unique “narrowing” behavior of PADMAL vessels and can manage your blood pressure and stroke prevention [3][4].
  • Neurogeneticist: A doctor who specializes in genetic brain diseases and can help interpret your specific mutation and its implications for your family [5][6].
  • Rehabilitation Specialists:
    • Speech-Language Pathologist (SLP): For managing dysarthria (slurred speech) and monitoring for dysphagia (swallowing difficulties) [7][8].
    • Physical Therapist (PT): To help with balance, gait, and strength as the disease progresses [9][10].
    • Occupational Therapist (OT): To adapt your home or workplace to keep you safe and independent [11][12].
  • Specialty Screeners: Depending on your specific variant and geneticist’s advice, because COL4A1 is used throughout the body, you may also need an Ophthalmologist to check for retinal changes and a Nephrologist to monitor kidney health [13][14][15].

Family and Future Planning

Since PADMAL is an autosomal dominant condition, each of your children has a 50% chance of inheriting the mutation (though this does not mean they will have the exact same severity) [16].

  • Genetic Counseling: This is a vital resource for your family. A counselor can help you navigate “predictive testing” for adult relatives who may not have symptoms yet but want to know their status [2][15].
  • Advanced Planning: PADMAL can cause vascular cognitive impairment over time [7][17]. It is helpful to discuss your healthcare proxy and financial preferences with your family while your thinking is clear, ensuring your wishes are respected even if processing speed or memory changes later [18][4].

Navigating Emergency Situations

One of the hardest parts of living with PADMAL is distinguishing between “the disease acting normally” and a “new emergency.” Knowledge is your best tool to prevent unnecessary panic.

What is NOT an Emergency

If you have a symptom that has been present and stable for weeks or months—such as slurred speech or a weak leg that you have already discussed with your neurologist—this is your baseline [7]. While these symptoms can be frustrating, they are part of the chronic disease process and can be managed during your regular clinic visits.

When to Seek Emergency Care

In PADMAL, a new event can be an ischemic stroke (a blocked vessel) or, less commonly, a hemorrhage (a bleed) [3][19]. If you experience any of the following sudden changes, call emergency services immediately:

  • Face: Sudden drooping on one side of your face.
  • Arms: Sudden new weakness or numbness in one arm or leg.
  • Speech: Speech that suddenly becomes significantly more slurred or difficult to understand than your “usual.”
  • Time: Act quickly; medical teams need to evaluate you immediately to see if acute treatments are safe [20][21].

Other Emergency Red Flags:

  • Sudden, severe headache that is different from any headache you have had before [22].
  • New, sudden double vision or loss of vision in one eye [23].
  • A new seizure or sudden, unexplained confusion [23][22].
  • Warning Strokes: If you have a “stereotyped” symptom (the same mild weakness or slurring) that happens suddenly, lasts for a few minutes, and then goes away, do not ignore it. These are medical emergencies. Call emergency services immediately; do not drive yourself to the hospital or wait to see if it resolves [21][24].

Safety Tip: Keep an emergency card that lists the time you were “last known well,” your exact genetic diagnosis, any known history of microbleeds/hemorrhage, and a complete list of your medications (especially blood thinners) to show the emergency clinicians.

By establishing a strong care team and knowing your baseline, you can focus on living your life while being prepared for whatever the journey brings.

Common questions in this guide

Which specialists are usually involved in PADMAL care?
A vascular neurologist and neurogeneticist can help coordinate the care plan. Speech-language, physical, and occupational therapists can address speech, swallowing, movement, balance, strength, safety, and independence. Depending on the genetic variant and clinical advice, an eye specialist and kidney specialist may also be involved.
How can I tell if a PADMAL symptom is my baseline or an emergency?
A symptom that has stayed stable for weeks or months and has already been discussed with your neurologist may be part of your baseline. A new symptom or a sudden change from your usual speech, strength, vision, or thinking needs emergency evaluation. If you are unsure, call emergency services rather than waiting.
What sudden symptoms mean I should call emergency services with PADMAL?
Call immediately for sudden facial drooping, new weakness or numbness, or speech that is much more difficult to understand than usual. Also seek emergency help for a sudden severe headache, new double vision or vision loss, a seizure, sudden confusion, or the same mild weakness or slurred speech that starts suddenly and then goes away. Do not drive yourself or wait for symptoms to resolve.
What information should be on my PADMAL emergency card?
List when you were last known to be well, your exact diagnosis, any history of brain microbleeds or bleeding, and every medication you take, especially blood thinners. Keep the card easy to find and show it to emergency clinicians. This information can help them assess sudden symptoms quickly.
How does PADMAL affect family planning and children?
PADMAL is autosomal dominant, so each child of a person with the mutation has a 50% chance of inheriting it. Inheriting the mutation does not determine exactly how severe the condition will be. A genetic counselor can discuss family planning and predictive testing for adult relatives.
Do people with PADMAL need eye and kidney checks?
Some people with PADMAL may need monitoring for retinal or kidney changes because COL4A1 is present throughout the body. The timing and type of screening depend on the specific genetic variant and advice from the care team. An ophthalmologist and nephrologist can provide these assessments.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is the primary 'quarterback' of my care team—the vascular neurologist or the neurogeneticist?
  2. 2.Can you help me document my current baseline for speech, motor skills, and memory so I can tell if something changes in the future?
  3. 3.Has a social worker or therapist on the team been assigned to help me with long-term disability or employment planning?
  4. 4.Which of my family members should see a genetic counselor, and do you have a specific recommendation for one familiar with COL4A1?
  5. 5.Beyond my brain, what is the schedule for monitoring my eyes and kidneys for other COL4A1-related changes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

    Mancuso M, Arnold M, Bersano A, et al.

    European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.

    PMID: 32196841
  2. 2

    Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management.

    Guey S, Lesnik Oberstein SAJ, Tournier-Lasserve E, Chabriat H

    Stroke 2021; (52(9)):3025-3032 doi:10.1161/STROKEAHA.121.032620.

    PMID: 34399586
  3. 3

    Recurrent Pontine Strokes in a Young Male.

    Grobe-Einsler M, Urbach H, Paus S

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2020; (29(12)):105386 doi:10.1016/j.jstrokecerebrovasdis.2020.105386.

    PMID: 33254373
  4. 4

    CADASIL: a practical review for the neurologist.

    Wan M, Hill MD

    Practical neurology 2026; doi:10.1136/pn-2025-004718.

    PMID: 42086327
  5. 5

    Monogenic causes of cerebral small vessel disease and stroke.

    Guey S, Chabriat H

    Handbook of clinical neurology 2024; (204()):273-287 doi:10.1016/B978-0-323-99209-1.00018-1.

    PMID: 39322384
  6. 6

    Hereditary cerebral small vessel disease and stroke.

    Søndergaard CB, Nielsen JE, Hansen CK, Christensen H

    Clinical neurology and neurosurgery 2017; (155()):45-57 doi:10.1016/j.clineuro.2017.02.015.

    PMID: 28254515
  7. 7

    Pontine autosomal dominant microangiopathy with leukoencephalopathy: Col4A1 gene variants in the original family and sporadic stroke.

    Roos J, Müller S, Giese A, et al.

    Journal of neurology 2023; (270(5)):2631-2639 doi:10.1007/s00415-023-11590-9.

    PMID: 36786861
  8. 8

    A rare cause of monogenic cerebral small vessel disease and stroke: Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL).

    Budhdeo S, de Paiva ARB, Wade C, et al.

    Journal of neurology 2022; (269(12)):6673-6677 doi:10.1007/s00415-022-11302-9.

    PMID: 35904593
  9. 9

    Rehabilitation for Individuals With Genetic Degenerative Ataxia: A Systematic Review.

    Milne SC, Corben LA, Georgiou-Karistianis N, et al.

    Neurorehabilitation and neural repair 2017; (31(7)):609-622 doi:10.1177/1545968317712469.

    PMID: 28595509
  10. 10

    Reduced macular vessel density and inner retinal thickness correlate with the severity of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

    Lin CW, Yang ZW, Chen CH, et al.

    PloS one 2022; (17(5)):e0268572 doi:10.1371/journal.pone.0268572.

    PMID: 35617208
  11. 11

    CADA-PRO: A Patient Questionnaire Measuring Key Cognitive, Motor, Emotional, and Behavioral Outcomes in CADASIL.

    Di Folco C, Jabouley A, Reyes S, et al.

    Stroke 2024; (55(10)):2439-2448 doi:10.1161/STROKEAHA.124.047692.

    PMID: 39234671
  12. 12

    COL4A1/COL4A2 gene duplication causing hereditary cerebral small vessel disease in a Chinese patient.

    Hou M, Du J, Qi X, Cao S

    Acta neurologica Belgica 2026; (126(3)):817-822 doi:10.1007/s13760-026-03011-1.

    PMID: 41784710
  13. 13

    Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.

    Gasparini S, Balestrini S, Saccaro LF, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2024; (196(4)):e32099 doi:10.1002/ajmg.c.32099.

    PMID: 39016117
  14. 14

    HANAC Syndrome Col4a1 Mutation Causes Neonate Glomerular Hyperpermeability and Adult Glomerulocystic Kidney Disease.

    Chen Z, Migeon T, Verpont MC, et al.

    Journal of the American Society of Nephrology : JASN 2016; (27(4)):1042-54 doi:10.1681/ASN.2014121217.

    PMID: 26260163
  15. 15

    COL4A1 and COL4A2-related disorders: Clinical features, diagnostic guidelines, and management.

    Tambala D, Vassar R, Snow J, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(9)):101514 doi:10.1016/j.gim.2025.101514.

    PMID: 40616396
  16. 16

    The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.

    Meuwissen ME, Halley DJ, Smit LS, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(11)):843-53 doi:10.1038/gim.2014.210.

    PMID: 25719457
  17. 17

    Cognition, mood and behavior in CADASIL.

    Chabriat H, Lesnik Oberstein S

    Cerebral circulation - cognition and behavior 2022; (3()):100043 doi:10.1016/j.cccb.2022.100043.

    PMID: 36324403
  18. 18

    A Novel Heterozygous Variant in Exon 19 of NOTCH3 in a Saudi Family with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

    Algahtani H, Shirah B, Alharbi SY, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2020; (29(7)):104832 doi:10.1016/j.jstrokecerebrovasdis.2020.104832.

    PMID: 32414585
  19. 19

    A Novel Mutation in COL4A1 Gene in a Chinese Family with Pontine Autosomal Dominant Microangiopathy and Leukoencephalopathy.

    Li Q, Wang C, Li W, et al.

    Translational stroke research 2022; (13(2)):238-244 doi:10.1007/s12975-021-00926-0.

    PMID: 34415564
  20. 20

    European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke.

    Wardlaw JM, Chabriat H, de Leeuw FE, et al.

    European stroke journal 2024; (9(1)):5-68 doi:10.1177/23969873231219416.

    PMID: 38380638
  21. 21

    Stroke warning syndromes.

    Sen A, Birns J, Bhalla A

    British journal of hospital medicine (London, England : 2005) 2020; (81(1)):1-5 doi:10.12968/hmed.2019.0222.

    PMID: 32003622
  22. 22

    Computed tomography-negative symptomatic intracerebral hemorrhage in a patient with cerebral small vessel disease: A case report.

    Han J, Yang H, Bae JH, et al.

    Medicine 2020; (99(29)):e21382 doi:10.1097/MD.0000000000021382.

    PMID: 32702937
  23. 23

    Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients.

    Drazyk AM, Tan RYY, Tay J, et al.

    Stroke 2019; (50(2)):283-290 doi:10.1161/STROKEAHA.118.023661.

    PMID: 30636574
  24. 24

    Heterogeneity of the capsular warning syndrome; experiences of a single centre.

    Boncuk Ulaş S, Acar T, Acar BA, et al.

    Annals of medicine 2025; (57(1)):2514942 doi:10.1080/07853890.2025.2514942.

    PMID: 40470813

This page is for informational purposes only and does not constitute medical advice. Your neurology team should tailor care and emergency plans to your situation; call emergency services for sudden neurologic changes.

Get notified when new evidence is published on Pontine autosomal dominant microangiopathy with leukoencephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.